PARIS – Pushing deeper into the research of skin’s microbiome, Swiss fragrance and flavors supplier Givaudan said on Tuesday that it has made new investments in its Applied Microbiomics Centre of Excellence.
The financial amount was not divulged, but the Vernier, Switzerland-based company, which calls itself the only fragrance supplier with in-house microbiome research capabilities, said the move is part of its 2020 strategy focused on strengthening its product offering for customers.
It also allows Givaudan to strengthen its foothold in a rapidly growing niche segment of the beauty industry, which focuses on skin’s microbiome – or microorganisms part of a specific environment – and includes products with pro- or prebiotic characteristics, for instance.
“Following the installation of state-of-the-art automation equipment at the Applied Microbiomics Centre of Excellence in Toulouse, France, Givaudan will accelerate the high throughput screenings to offer more disruptive solutions for customers,” the company said in a statement. “With over 15 years’ experience in the field of microbiomics, Givaudan Active Beauty continues to develop active cosmetic ingredients, designed to activate, protect or balance the skin microbiota.”
Givaudan said its scientists were the first to discover the creation of microbiome-activated ingredients and microbiome-protecting agents, resulting in the active cosmetics ingredients Brightenyl and Revivyl.
You May Also Like
Givaudan’s Active Beauty branch, which is part of the company’s Fragrance Division, offers products with benefits including anti-aging, self-tanning, soothing, moisturizing and cooling.
Givaudan, the world’s largest fragrance and flavors suppliers, registered sales of 5.1 billion Swiss francs, or $5.46 billion, last year, and employs more than 11,100 people worldwide.